Your browser doesn't support javascript.
loading
The clinicopathologic spectrum and genomic landscape of de-/trans-differentiated melanoma.
Ferreira, Ingrid; Droop, Alastair; Edwards, Olivia; Wong, Kim; Harle, Victoria; Habeeb, Omar; Gharpuray-Pandit, Deepa; Houghton, Joseph; Wiedemeyer, Katharina; Mentzel, Thomas; Billings, Steven D; Ko, Jennifer S; Füzesi, Laszlo; Mulholland, Kathleen; Prusac, Ivana Kuzmic; Liegl-Atzwanger, Bernadette; de Saint Aubain, Nicolas; Caldwell, Helen; Riva, Laura; van der Weyden, Louise; Arends, Mark J; Brenn, Thomas; Adams, David J.
Afiliação
  • Ferreira I; Experimental Cancer Genetics, Wellcome Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK.
  • Droop A; Université Libre de Bruxelles, Brussels, Belgium.
  • Edwards O; Experimental Cancer Genetics, Wellcome Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK.
  • Wong K; Experimental Cancer Genetics, Wellcome Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK.
  • Harle V; Experimental Cancer Genetics, Wellcome Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK.
  • Habeeb O; Experimental Cancer Genetics, Wellcome Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK.
  • Gharpuray-Pandit D; Department of Anatomic Pathology, Middlemore Hospital, Auckland, NZ, New Zealand.
  • Houghton J; Department of Cellular Pathology, Royal Preston Hospital, Preston, UK.
  • Wiedemeyer K; Department of Pathology, Royal Victoria Hospital, Belfast, Ireland.
  • Mentzel T; Department of Dermatology, University of Heidelberg, Heidelberg, Germany.
  • Billings SD; Department of Pathology and Laboratory Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
  • Ko JS; Dermatopathology Friedrichshafen, Friedrichshafen, Germany.
  • Füzesi L; Department of Pathology, Cleveland Clinic, Cleveland, OH, USA.
  • Mulholland K; Department of Pathology, Cleveland Clinic, Cleveland, OH, USA.
  • Prusac IK; Center for Pathology, Robert-Weixler-Straße 48a, Kempten, Germany.
  • Liegl-Atzwanger B; Department of Pathology, Altnagelvin Area Hospital, Londonderry, UK.
  • de Saint Aubain N; Department of Pathology, University Hospital Split and Split University School of Medicine, Split, Croatia.
  • Caldwell H; Diagnostic and Research Centre for Molecular Biomedicine, Diagnostic and Research Centre for Pathology, Translational Sarcoma Pathology, Comprehensive Cancer Centre Subunit Sarcoma, Medical University Graz, Graz, Austria.
  • Riva L; Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.
  • van der Weyden L; Division of Pathology, Cancer Research UK Edinburgh Centre, The University of Edinburgh, Institute of Genetics and Cancer, Edinburgh, UK.
  • Arends MJ; Experimental Cancer Genetics, Wellcome Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK.
  • Brenn T; Experimental Cancer Genetics, Wellcome Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK.
  • Adams DJ; Division of Pathology, Cancer Research UK Edinburgh Centre, The University of Edinburgh, Institute of Genetics and Cancer, Edinburgh, UK.
Mod Pathol ; 34(11): 2009-2019, 2021 11.
Article em En | MEDLINE | ID: mdl-34155350
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Genômica / Neurofibromina 1 / Melanoma Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Genômica / Neurofibromina 1 / Melanoma Idioma: En Ano de publicação: 2021 Tipo de documento: Article